Entropy Neurodynamics Limited
ENP
Ранг среди акций
#26196
Entropy Neurodynamics Limited operates as a clinical-stage pharmaceutical... Entropy Neurodynamics Limited operates as a clinical-stage pharmaceutical company, dedicated to pioneering novel formulations for psilocin administration. These formulations are intended for use alongside psychotherapy, aiming to tackle medical conditions with pressing unmet needs across Australia, Canada, Switzerland, and the United States. The firm's flagship development is TRP-8803, an intravenously infused psilocin formulation that has successfully concluded Phase 2 clinical trials. These trials investigated its potential to treat binge eating disorder, fibromyalgia, irritable bowel syndrome, abdominal pain, and visceral tenderness. Additionally, the company is advancing TRP-8802, a synthetic, orally administered psilocybin compound. TRP-8802 is currently undergoing Phase 2a clinical trials for binge eating and is in Phase 2 clinical development for fibromyalgia and irritable bowel syndrome. Established in 2019 and headquartered in Camberwell, Australia, the company adopted its current name, Entropy Neurodynamics Limited, in November 2025, having previously operated as Tryptamine Therapeutics Limited.
Цена акции
$0.02468497
Последняя синхронизация: 2026-07-30
Рыночная капитализация
$40.28M
Изменение (1 день)
0.00%
Изменение (1 год)
-56.08%
Страна
AU
Торговля Entropy Neurodynamics Limited (ENP)
Категория
Healthcare
Рыночная капитализация Entropy Neurodynamics Limited(ENP)
Рыночная капитализация: $40.28M
По состоянию на October 2026 рыночная капитализация Entropy Neurodynamics Limited составляет $40.28M. Согласно нашим данным, Entropy Neurodynamics Limited занимает 26196th место среди самых ценных компаний мира по рыночной капитализации. Рыночная капитализация — это общая рыночная стоимость всех находящихся в обращении акций публичной компании и обычно используется для оценки ее стоимости.
История рыночной капитализации Entropy Neurodynamics Limited с 2021 по 2026
ENP по сравнению с пятеркой самых популярных stocks
